awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28303718-1DF698F7-18CC-40EC-8876-AA1042A39903
Q28303718-1DF698F7-18CC-40EC-8876-AA1042A39903
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28303718-1DF698F7-18CC-40EC-8876-AA1042A39903
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma
P2860
Q28303718-1DF698F7-18CC-40EC-8876-AA1042A39903
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28303718-1DF698F7-18CC-40EC-8876-AA1042A39903
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3f5467a8aa9e52f9e91886f4857c58b0b75b577f
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.